Literature DB >> 11744567

Science, medicine, and the future: Genetics and cardiovascular risk.

I N Day1, D I Wilson.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11744567      PMCID： PMC1121864          DOI： 10.1136/bmj.323.7326.1409

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  18 in total

1.  The use of long PCR to confirm three common alleles at the CYP2A6 locus and the relationship between genotype and smoking habit.

Authors:  D F Gu; L J Hinks; N E Morton; I N Day
Journal:  Ann Hum Genet       Date:  2000-09       Impact factor: 1.670

Review 2.  Molecular and cellular mechanisms of cardiac arrhythmias.

Authors:  M T Keating; M C Sanguinetti
Journal:  Cell       Date:  2001-02-23       Impact factor: 41.582

Review 3.  Gene therapy for restenosis after balloon angioplasty and stenting.

Authors:  C Indolfi; C Coppola; D Torella; O Arcucci; M Chiariello
Journal:  Cardiol Rev       Date:  1999 Nov-Dec       Impact factor: 2.644

4.  Evidence for a third genetic locus causing familial hypercholesterolemia. A non-LDLR, non-APOB kindred.

Authors:  L Haddad; I N Day; S Hunt; R R Williams; S E Humphries; P N Hopkins
Journal:  J Lipid Res       Date:  1999-06       Impact factor: 5.922

5.  Elastin: genomic structure and point mutations in patients with supravalvular aortic stenosis.

Authors:  M Tassabehji; K Metcalfe; D Donnai; J Hurst; W Reardon; M Burch; A P Read
Journal:  Hum Mol Genet       Date:  1997-07       Impact factor: 6.150

Review 6.  The 22q11 deletion syndromes.

Authors:  P J Scambler
Journal:  Hum Mol Genet       Date:  2000-10       Impact factor: 6.150

7.  Familial risks of congenital heart defect assessed in a population-based epidemiologic study.

Authors:  J A Boughman; K A Berg; J A Astemborski; E B Clark; R J McCarter; J D Rubin; C Ferencz
Journal:  Am J Med Genet       Date:  1987-04

8.  Differences in the phenotypic characteristics of subjects with familial defective apolipoprotein B-100 and familial hypercholesterolemia.

Authors:  A R Miserez; U Keller
Journal:  Arterioscler Thromb Vasc Biol       Date:  1995-10       Impact factor: 8.311

9.  A pilot study of ex vivo gene therapy for homozygous familial hypercholesterolaemia.

Authors:  M Grossman; D J Rader; D W Muller; D M Kolansky; K Kozarsky; B J Clark; E A Stein; P J Lupien; H B Brewer; S E Raper
Journal:  Nat Med       Date:  1995-11       Impact factor: 53.440

10.  Genetic and environmental factors affecting the incidence of coronary artery disease in heterozygous familial hypercholesterolemia.

Authors:  J S Hill; M R Hayden; J Frohlich; P H Pritchard
Journal:  Arterioscler Thromb       Date:  1991 Mar-Apr
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.